2014, ISBN 9789956447725, iv, 182
Book
2011, 1. Aufl., ISBN 3869558652, xi, 208
Book
NATURE, ISSN 0028-0836, 03/2019, Volume 567, Issue 7747, pp. 147 - 147
According to the World Bank, Africa needs between US$2 billion and $3.5 billion a year for epidemic preparedness; in 2015, 8 African nations received from...
MULTIDISCIPLINARY SCIENCES | Leadership | Africa - epidemiology | Developing Countries - economics | Humans | Disease Outbreaks - statistics & numerical data | Disease Outbreaks - economics | United Nations - organization & administration | Communicable Disease Control - trends | Public Health Surveillance | Global Health - trends | Acquired Immunodeficiency Syndrome - epidemiology | Acquired Immunodeficiency Syndrome - mortality | Disease Outbreaks - prevention & control | Politics | Communicable Disease Control - organization & administration | Prevention | Epidemics | Africa | Public health | Ebola virus | Pandemics | Bacterial infections | Acquired immune deficiency syndrome--AIDS | Surveillance | Human immunodeficiency virus--HIV | Outbreaks | Informatics | Disease control | Gene sequencing
MULTIDISCIPLINARY SCIENCES | Leadership | Africa - epidemiology | Developing Countries - economics | Humans | Disease Outbreaks - statistics & numerical data | Disease Outbreaks - economics | United Nations - organization & administration | Communicable Disease Control - trends | Public Health Surveillance | Global Health - trends | Acquired Immunodeficiency Syndrome - epidemiology | Acquired Immunodeficiency Syndrome - mortality | Disease Outbreaks - prevention & control | Politics | Communicable Disease Control - organization & administration | Prevention | Epidemics | Africa | Public health | Ebola virus | Pandemics | Bacterial infections | Acquired immune deficiency syndrome--AIDS | Surveillance | Human immunodeficiency virus--HIV | Outbreaks | Informatics | Disease control | Gene sequencing
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2012, Volume 7, Issue 3, p. e33328
Background: Accurate and reliable laboratory methods are needed for estimation of HIV-1 incidence to identify the high-risk populations and target and monitor...
ANTIBODIES | INCIDENCE RATES | WOMEN | SEROCONVERSION | SUBTYPE-E INFECTION | TYPE-1 INCIDENCE | MULTIDISCIPLINARY SCIENCES | PERFORMANCE-CHARACTERISTICS | CAPTURE ENZYME-IMMUNOASSAY | TRENDS | ACCURACY | HIV Antibodies - blood | HIV Infections - blood | HIV Seropositivity - blood | Reproducibility of Results | Humans | Antibody Affinity - immunology | HIV Seropositivity - diagnosis | Viral Load | HIV Infections - immunology | HIV-1 - immunology | HIV-1 - growth & development | HIV Antibodies - immunology | HIV Antigens - immunology | Immunoenzyme Techniques - methods | HIV Infections - diagnosis | Sensitivity and Specificity | HIV Seropositivity - immunology | Longitudinal Studies | Viral antibodies | Antigens | Enzymes | AIDS vaccines | Tuberculosis | HIV testing | Antibodies | HIV (Viruses) | Health aspects | Risk factors | Immunoassay | Epidemics | Populations | Laboratories | Identification methods | Immunoglobulin G | Oligonucleotides | Clinical trials | Infections | Serology | Coefficient of variation | Optimization | Incidence | Prevention | Proteins | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Immunization | Immunoglobulins | Risk groups | Maturation | Health risks | Risk analysis | Enzyme immunoassay | Estimates | Disease control | Constraining | Optical density | Studies | Surveillance | Reproducibility | Quality control | Avidity | Kinetics | Laboratory methods | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
ANTIBODIES | INCIDENCE RATES | WOMEN | SEROCONVERSION | SUBTYPE-E INFECTION | TYPE-1 INCIDENCE | MULTIDISCIPLINARY SCIENCES | PERFORMANCE-CHARACTERISTICS | CAPTURE ENZYME-IMMUNOASSAY | TRENDS | ACCURACY | HIV Antibodies - blood | HIV Infections - blood | HIV Seropositivity - blood | Reproducibility of Results | Humans | Antibody Affinity - immunology | HIV Seropositivity - diagnosis | Viral Load | HIV Infections - immunology | HIV-1 - immunology | HIV-1 - growth & development | HIV Antibodies - immunology | HIV Antigens - immunology | Immunoenzyme Techniques - methods | HIV Infections - diagnosis | Sensitivity and Specificity | HIV Seropositivity - immunology | Longitudinal Studies | Viral antibodies | Antigens | Enzymes | AIDS vaccines | Tuberculosis | HIV testing | Antibodies | HIV (Viruses) | Health aspects | Risk factors | Immunoassay | Epidemics | Populations | Laboratories | Identification methods | Immunoglobulin G | Oligonucleotides | Clinical trials | Infections | Serology | Coefficient of variation | Optimization | Incidence | Prevention | Proteins | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Immunization | Immunoglobulins | Risk groups | Maturation | Health risks | Risk analysis | Enzyme immunoassay | Estimates | Disease control | Constraining | Optical density | Studies | Surveillance | Reproducibility | Quality control | Avidity | Kinetics | Laboratory methods | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
The Lancet, ISSN 0140-6736, 06/2018, Volume 391, Issue 10138, pp. 2395 - 2398
[...]four cases have been identified in Wangata, a district of Mbandaka, the capital of the Equateur Province with an estimated population of 1·2 million...
MEDICINE, GENERAL & INTERNAL | Democratic Republic of the Congo - epidemiology | Hemorrhagic Fever, Ebola - prevention & control | Time Factors | Disease Outbreaks | Humans | International Cooperation | Hemorrhagic Fever, Ebola - epidemiology | Ebola virus | Epidemics | Immunization | Viral diseases | Viruses | Outbreaks | Vaccines | Disease control
MEDICINE, GENERAL & INTERNAL | Democratic Republic of the Congo - epidemiology | Hemorrhagic Fever, Ebola - prevention & control | Time Factors | Disease Outbreaks | Humans | International Cooperation | Hemorrhagic Fever, Ebola - epidemiology | Ebola virus | Epidemics | Immunization | Viral diseases | Viruses | Outbreaks | Vaccines | Disease control
Journal Article
Journal of Postcolonial Writing, ISSN 1744-9855, 02/2012, Volume 48, Issue 1, pp. 51 - 64
Anglophone Cameroon poetry deals with a peculiar postcolonial political situation in Africa, in which two peoples of opposing colonial experiences were brought...
Cameroon | John Ngong Kum Ngong | history | Bate Besong | anglophone problem | poetry | LITERATURE | Twentieth Century | Cameroon National Identity | Ngong Kum Ngong, John | Authors | Besong, Bate | English Literature | Twenty-First Century | Postcolonialism
Cameroon | John Ngong Kum Ngong | history | Bate Besong | anglophone problem | poetry | LITERATURE | Twentieth Century | Cameroon National Identity | Ngong Kum Ngong, John | Authors | Besong, Bate | English Literature | Twenty-First Century | Postcolonialism
Journal Article
10.
Full Text
Laboratory medicine in low-income and middle-income countries: progress and challenges
The Lancet, ISSN 0140-6736, 05/2018, Volume 391, Issue 10133, pp. 1873 - 1875
Laboratory medicine is essential for disease detection, surveillance, control, and management.1 However, access to quality-assured laboratory diagnosis has...
MEDICINE, GENERAL & INTERNAL | SYSTEMS | Medicine | Low income groups | Disease prevention | Advocacy | Surveillance | Medical laboratories | Innovations | Income | Accreditation | Disease control | Standards | Public health
MEDICINE, GENERAL & INTERNAL | SYSTEMS | Medicine | Low income groups | Disease prevention | Advocacy | Surveillance | Medical laboratories | Innovations | Income | Accreditation | Disease control | Standards | Public health
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2017, Volume 12, Issue 6, p. e0179316
Background Routine HIV viral load testing is not widely accessible in most resource-limited settings, including Kenya. To increase access to viral load...
VERSION 2.0 | WHOLE-BLOOD | AFRICA | SPECIMENS | RESOURCE-LIMITED SETTINGS | THERAPY | RNA | QUANTIFICATION | MULTIDISCIPLINARY SCIENCES | FILTER-PAPER | ANTIRETROVIRAL TREATMENT | HIV Infections - blood | Viral Load - instrumentation | HIV-1 - metabolism | Kenya - epidemiology | HIV Infections - epidemiology | HIV Infections - genetics | Humans | Male | HIV-1 - genetics | Polymerase Chain Reaction - methods | Dried Blood Spot Testing - instrumentation | Dried Blood Spot Testing - methods | Sensitivity and Specificity | Female | Polymerase Chain Reaction - instrumentation | Viral Load - methods | Antiviral agents | Complications and side effects | Usage | HIV testing | Dosage and administration | Diagnosis | Research | Drug therapy | HIV infection | Methods | Antiretroviral drugs | Correlation | Separation | Thresholds | Accessibility | Cut-off | Assaying | Patients | Blood | Optimization | Confidence intervals | Disease prevention | Sensitivity | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Spots | AIDS | HIV | Acquired immune deficiency syndrome | Human immunodeficiency virus
VERSION 2.0 | WHOLE-BLOOD | AFRICA | SPECIMENS | RESOURCE-LIMITED SETTINGS | THERAPY | RNA | QUANTIFICATION | MULTIDISCIPLINARY SCIENCES | FILTER-PAPER | ANTIRETROVIRAL TREATMENT | HIV Infections - blood | Viral Load - instrumentation | HIV-1 - metabolism | Kenya - epidemiology | HIV Infections - epidemiology | HIV Infections - genetics | Humans | Male | HIV-1 - genetics | Polymerase Chain Reaction - methods | Dried Blood Spot Testing - instrumentation | Dried Blood Spot Testing - methods | Sensitivity and Specificity | Female | Polymerase Chain Reaction - instrumentation | Viral Load - methods | Antiviral agents | Complications and side effects | Usage | HIV testing | Dosage and administration | Diagnosis | Research | Drug therapy | HIV infection | Methods | Antiretroviral drugs | Correlation | Separation | Thresholds | Accessibility | Cut-off | Assaying | Patients | Blood | Optimization | Confidence intervals | Disease prevention | Sensitivity | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Spots | AIDS | HIV | Acquired immune deficiency syndrome | Human immunodeficiency virus
Journal Article
Clinical Microbiology Reviews, ISSN 0893-8512, 04/2011, Volume 24, Issue 2, pp. 314 - 350
Classifications Services CMR Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit...
REAL-TIME PCR | COMMERCIAL URINARY LIPOARABINOMANNAN | MEDIATED ISOTHERMAL AMPLIFICATION | MULTIDRUG-RESISTANT TUBERCULOSIS | NUCLEIC-ACID AMPLIFICATION | PULMONARY TUBERCULOSIS | SPUTUM SMEAR MICROSCOPY | GENOTYPE MTBDR ASSAY | MICROBIOLOGY | SLOWLY GROWING MYCOBACTERIA | RAPID DETECTION | Tuberculosis - epidemiology | Clinical Laboratory Techniques - methods | Developing Countries | Medical Laboratory Science - methods | Tuberculosis - diagnosis | Humans | Reviews
REAL-TIME PCR | COMMERCIAL URINARY LIPOARABINOMANNAN | MEDIATED ISOTHERMAL AMPLIFICATION | MULTIDRUG-RESISTANT TUBERCULOSIS | NUCLEIC-ACID AMPLIFICATION | PULMONARY TUBERCULOSIS | SPUTUM SMEAR MICROSCOPY | GENOTYPE MTBDR ASSAY | MICROBIOLOGY | SLOWLY GROWING MYCOBACTERIA | RAPID DETECTION | Tuberculosis - epidemiology | Clinical Laboratory Techniques - methods | Developing Countries | Medical Laboratory Science - methods | Tuberculosis - diagnosis | Humans | Reviews
Journal Article
American Journal of Clinical Pathology, ISSN 0002-9173, 09/2010, Volume 134, Issue 3, pp. 359 - 360
Journal Article
PLoS Medicine, ISSN 1549-1277, 03/2011, Volume 8, Issue 3, p. e1000430
Background: Nevirapine and lamivudine given to mothers are transmitted to infants via breastfeeding in quantities sufficient to have biologic effects on the...
MEDICINE, GENERAL & INTERNAL | THERAPY | ZIDOVUDINE | HIVNET-012 | INTRAPARTUM | RANDOMIZED-TRIAL | PREGNANT-WOMEN | VERTICAL TRANSMISSION | NEVIRAPINE | MILK | Anti-HIV Agents - pharmacology | HIV Infections - prevention & control | HIV-1 - drug effects | HIV Infections - virology | Humans | Breast Feeding | HIV-1 - genetics | Kenya | Mutation - genetics | Mothers | Drug Resistance, Viral - genetics | HIV-1 - immunology | HIV-1 - physiology | Polymerase Chain Reaction | Anti-HIV Agents - therapeutic use | Drug Resistance, Viral - drug effects | Female | HIV Infections - drug therapy | HIV Infections - transmission | Viral Load - drug effects | Infectious Disease Transmission, Vertical - prevention & control | Infant, Newborn | Cohort Studies | HIV Seropositivity - virology | Prevention | Antiviral agents | Viral drug resistance | Disease transmission | Pregnant women | Research | HIV infection | Health aspects | Studies | Antiretroviral drugs | Medical research | Human immunodeficiency virus--HIV | Mutation | Drug resistance | Drug therapy | Children & youth | HIV | Human immunodeficiency virus
MEDICINE, GENERAL & INTERNAL | THERAPY | ZIDOVUDINE | HIVNET-012 | INTRAPARTUM | RANDOMIZED-TRIAL | PREGNANT-WOMEN | VERTICAL TRANSMISSION | NEVIRAPINE | MILK | Anti-HIV Agents - pharmacology | HIV Infections - prevention & control | HIV-1 - drug effects | HIV Infections - virology | Humans | Breast Feeding | HIV-1 - genetics | Kenya | Mutation - genetics | Mothers | Drug Resistance, Viral - genetics | HIV-1 - immunology | HIV-1 - physiology | Polymerase Chain Reaction | Anti-HIV Agents - therapeutic use | Drug Resistance, Viral - drug effects | Female | HIV Infections - drug therapy | HIV Infections - transmission | Viral Load - drug effects | Infectious Disease Transmission, Vertical - prevention & control | Infant, Newborn | Cohort Studies | HIV Seropositivity - virology | Prevention | Antiviral agents | Viral drug resistance | Disease transmission | Pregnant women | Research | HIV infection | Health aspects | Studies | Antiretroviral drugs | Medical research | Human immunodeficiency virus--HIV | Mutation | Drug resistance | Drug therapy | Children & youth | HIV | Human immunodeficiency virus
Journal Article
BMC Public Health, ISSN 1471-2458, 2010, Volume 10, Issue 1, pp. S5 - 5
There is increased interest in strengthening health systems for developing countries. However, at present, there is common uncertainty about how to accomplish...
PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | H1N1 VIRUS | Guidelines as Topic | World Health Organization | Humans | Public Health Practice - standards | Health Manpower | Program Development | Health Systems Plans | Communicable Diseases, Emerging - prevention & control | Organizational Objectives | Systems Analysis | Disaster Planning | Interinstitutional Relations | Developing Countries | Population Surveillance - methods
PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | H1N1 VIRUS | Guidelines as Topic | World Health Organization | Humans | Public Health Practice - standards | Health Manpower | Program Development | Health Systems Plans | Communicable Diseases, Emerging - prevention & control | Organizational Objectives | Systems Analysis | Disaster Planning | Interinstitutional Relations | Developing Countries | Population Surveillance - methods
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 1, pp. e26 - e29
Summary Scaling up access to HIV viral load testing for individuals undergoing antiretroviral therapy in low-resource settings is a global health priority, as...
Infectious Disease | RESISTANCE | INFECTIOUS DISEASES | COST-EFFECTIVENESS | RESOURCE-LIMITED SETTINGS | HIV Infections - prevention & control | Point-of-Care Systems - organization & administration | Global Health | HIV Infections - virology | Humans | Specimen Handling - methods | Viral Load | Desiccation - methods | Blood - virology | Anti-HIV Agents - therapeutic use | HIV Infections - drug therapy | Medical Laboratory Science - organization & administration | Antiretroviral Therapy, Highly Active - methods | Drug Monitoring | Health Policy | Prevention | Highly active antiretroviral therapy | Medical colleges | Antiviral agents | AIDS treatment | Nurses | Medical care | HIV testing | HIV (Viruses) | Drug therapy | Public health | Quality management | Medical tests | Antiretroviral drugs | Acquired immune deficiency syndrome--AIDS | Protease inhibitors | Drug resistance | Laboratories | Human immunodeficiency virus--HIV
Infectious Disease | RESISTANCE | INFECTIOUS DISEASES | COST-EFFECTIVENESS | RESOURCE-LIMITED SETTINGS | HIV Infections - prevention & control | Point-of-Care Systems - organization & administration | Global Health | HIV Infections - virology | Humans | Specimen Handling - methods | Viral Load | Desiccation - methods | Blood - virology | Anti-HIV Agents - therapeutic use | HIV Infections - drug therapy | Medical Laboratory Science - organization & administration | Antiretroviral Therapy, Highly Active - methods | Drug Monitoring | Health Policy | Prevention | Highly active antiretroviral therapy | Medical colleges | Antiviral agents | AIDS treatment | Nurses | Medical care | HIV testing | HIV (Viruses) | Drug therapy | Public health | Quality management | Medical tests | Antiretroviral drugs | Acquired immune deficiency syndrome--AIDS | Protease inhibitors | Drug resistance | Laboratories | Human immunodeficiency virus--HIV
Journal Article
2018
Book
Clinical Infectious Diseases, ISSN 1058-4838, 4/2012, Volume 54, Issue 8, pp. 1187 - 1195
Background. Antiretroviral therapy (ART) is being administered in developing nations at unprecedented numbers following the World Health Organization's (WHO)...
HIV/AIDS | Antiretrovirals | HIV | Specimens | AIDS | Drug resistance | Viral load | Blood | Blood plasma | HIV 1 | Virology | DIAGNOSIS | INFECTIOUS DISEASES | ASSAY | PREVENTION | MICROBIOLOGY | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | CHILDBEARING WOMEN | TRANSMITTED HIV | WHOLE-BLOOD | PLASMA | SURVEILLANCE | MUTATIONS | Desiccation | HIV Infections - virology | Humans | Specimen Handling - methods | Drug Monitoring - methods | Anti-HIV Agents - administration & dosage | Antiretroviral Therapy, Highly Active | HIV-1 - isolation & purification | Blood - virology | HIV Infections - drug therapy | Nigeria | Viral Load - methods | Microbial Sensitivity Tests - methods | Drugs | Measurement | Dose-response relationship (Biochemistry) | Antiviral agents | Usage | Medical examination | Viremia | HIV patients | Product/Service Evaluations | HIV testing | Dosage and administration | Diagnosis | Drug therapy | HIV infection
HIV/AIDS | Antiretrovirals | HIV | Specimens | AIDS | Drug resistance | Viral load | Blood | Blood plasma | HIV 1 | Virology | DIAGNOSIS | INFECTIOUS DISEASES | ASSAY | PREVENTION | MICROBIOLOGY | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | CHILDBEARING WOMEN | TRANSMITTED HIV | WHOLE-BLOOD | PLASMA | SURVEILLANCE | MUTATIONS | Desiccation | HIV Infections - virology | Humans | Specimen Handling - methods | Drug Monitoring - methods | Anti-HIV Agents - administration & dosage | Antiretroviral Therapy, Highly Active | HIV-1 - isolation & purification | Blood - virology | HIV Infections - drug therapy | Nigeria | Viral Load - methods | Microbial Sensitivity Tests - methods | Drugs | Measurement | Dose-response relationship (Biochemistry) | Antiviral agents | Usage | Medical examination | Viremia | HIV patients | Product/Service Evaluations | HIV testing | Dosage and administration | Diagnosis | Drug therapy | HIV infection
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2017, Volume 12, Issue 2, p. e0173009
Background Efforts to reach UNAIDS' treatment and viral suppression targets have increased demand for viral load (VL) testing and strained existing laboratory...
MORTALITY | AFRICA | RESOURCE-LIMITED SETTINGS | QUALITY | THERAPY | MULTIDISCIPLINARY SCIENCES | ANTIRETROVIRAL TREATMENT | HIV Infections - blood | Molecular Diagnostic Techniques | Time Factors | HIV-1 - isolation & purification | Malawi | HIV Infections - diagnosis | HIV Infections - virology | Humans | Infant | HIV-1 - genetics | Viral Load | Measurement | Care and treatment | Viremia | Analysis | HIV (Viruses) | Patient compliance | Risk factors | Epidemics | Antiretroviral drugs | Statistical analysis | Laboratories | Management systems | Mortality | Switches | Switching theory | Data processing | Statistical methods | Regression analysis | Disease control | Load tests | Confidence intervals | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Collection | Median (statistics) | Quality management | AIDS | HIV | Acquired immune deficiency syndrome | Human immunodeficiency virus
MORTALITY | AFRICA | RESOURCE-LIMITED SETTINGS | QUALITY | THERAPY | MULTIDISCIPLINARY SCIENCES | ANTIRETROVIRAL TREATMENT | HIV Infections - blood | Molecular Diagnostic Techniques | Time Factors | HIV-1 - isolation & purification | Malawi | HIV Infections - diagnosis | HIV Infections - virology | Humans | Infant | HIV-1 - genetics | Viral Load | Measurement | Care and treatment | Viremia | Analysis | HIV (Viruses) | Patient compliance | Risk factors | Epidemics | Antiretroviral drugs | Statistical analysis | Laboratories | Management systems | Mortality | Switches | Switching theory | Data processing | Statistical methods | Regression analysis | Disease control | Load tests | Confidence intervals | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Collection | Median (statistics) | Quality management | AIDS | HIV | Acquired immune deficiency syndrome | Human immunodeficiency virus
Journal Article